[ad_1]
SINGAPORE, SINGAPORE, Could 14th, 2024, Chainwire
Vyvo Good Chain, a HealthFi ecosystem that rewards well being monitoring via knowledge monetization, right now introduced that Vyvo has obtained U.S. Meals and Drug Administration (FDA) clearance for LifeWatch, the corporate’s revolutionary wearable machine for well being & wellness monitoring. This achievement marks a major leap ahead within the convergence of blockchain know-how and well being monitoring.
Vyvo’s LifeWatch pioneers a brand new period in well being and wellness. LifeWatch promotes a user-centric well being monitoring mannequin and leverages Decentralized Bodily Infrastructure community (DePIN) know-how to permit customers to monetize their well being knowledge. This ensures privateness, anonymity, and full possession and management over private well being knowledge, empowering customers to securely handle and monetize their info.
Fabio Galdi, Co-Founder and CEO of Vyvo, said, “This approval marks a major development in integrating blockchain know-how into well being and wellness. Our dedication is to innovation and consumer empowerment, and this FDA clearance positions us to proceed difficult the present norms and lead a change in well being options.”
Vyvo not solely empowers customers with superior wellness monitoring instruments but in addition fosters a safe and clear ecosystem for well being knowledge, powered by blockchain know-how. By frequently pushing the boundaries of digital well being administration, Vyvo opens up new avenues for people to take cost of their well-being.
Vyvo’s wearable gadgets can be found at helohealth.com. To study extra about VSC and incomes rewards via well being monitoring, customers can go to vyvo.com.
About Vyvo Good Chain
Vyvo Good Chain is a HealthFi ecosystem that rewards well being monitoring via knowledge monetization on IoT gadgets. Vyvo makes it simple for individuals to know and observe their physique stats, safe well being knowledge privateness and earn rewards for doing so whereas contributing to analysis into new medication, growing remedies, and stopping the unfold of ailments.
take away adverts
.
ContactMike Evansmike@multipliedhq.com
This text was initially printed on Chainwire
[ad_2]
Source link